Thromboxane mediates pulmonary hypertension and lung inflammation during hyperacute lung rejection

Journal of Applied Physiology

Volumn 90, Issue 6, 2001, Pages 2257-2268

  Collins, Brendan J ^a   Blum, Matthew G ^a   Parker, Richard E ^a   Chang, Andrew C ^a   Blair, Kelly S A ^a   Zorn III, George L ^a   Christman, Brian W ^a   Pierson III, Richard N ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Eicosanoid; Macrophage; Microvascular permeability; Neutrophil; Platelet; Xenotransplantation

Indexed keywords

THROMBOXANE;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; GRAFT REJECTION; HUMAN; LUNG TRANSPLANTATION; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PULMONARY HYPERTENSION; XENOTRANSPLANTATION;

EID: 0035023202     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.2001.90.6.2257     Document Type: Article

References (44)

1. Bach FH, Ferran C, Hechenleitner P, Mark W, Koyamada N, Miyatake T, Winkler H, Baduchani A, Candinas D, and Hancock WW. Accommodation of vascularized xenografts: expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment. Nat Med 3: 196-204, 1997.
2. 2 receptor activation elicits organ-specific increases in microvascular permeability in the rat. Am J Physiol Regulatory Integrative Comp Physiol 268: R366-R374, 1995.
3. Blum MG, Collins BJ, Chang AC, Zhang JP, Knauss SA, and Pierson RN III. Complement inhibition by FUT-175 and K76-COOH in a pig-to-human lung xenotransplant model. Xenotransplantation 5: 35-43, 1998.
4. Brigham KL and Duke S. Prostaglandins and lung disease: adult respiratory distress syndrome. Semin Respir Med 7: 11-16, 1985.
5. Brigham KL and Meyrick BO. State of the art: endotoxin and lung injury. Am Rev Respir Dis 133: 913-927, 1986.
6. Bustos M, Coffman TM, Saadi S, and Platt JL. Modulation of eicosanoid metabolism in endothelial cells in a xenograft model. J Clin Invest 100: 1150-1158, 1997.
7. Byrne GW, McCurry KR, Martin MJ, Mclellan SM, Platt JL, and Logan JS. Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage. Transplantation 63: 149-155 1997.
8. Catella F and FitzGerald GA. Measurement of thromboxane metabolites by gas chromatography-mass spectrometry. Methods Enzymol 187: 42-50, 1990.
9. Christman BW, McPherson CD, Newman JH, King GA, Bernard GR, Groves BM, and Loyd JE. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med 327: 70-75, 1992.
10. Demling RH, Smith M, Gunther R, Flynn JT, and Gee MH. Pulmonary injury and prostaglandin production during endotoxemia in conscious sheep (Abstract). Am J Physiol Heart Circ Physiol 240: H348, 1981.
11. Failing J, Buckley M, and Zack D. Automated determination of serum protein. Am J Clin Pathol 33: 83-88, 1960.
12. Finger EB, Puri KD, Alon R, Lawrence MB, von Andrian UH, and Springer TA. Adhesion through L-selectin requires a threshold hydrodynamic shear (Abstract). Nature 379: 266, 1996.
13. Imagawa DK, Osifchin NE, Ramm LE, Koga PG, Hammer CH, Shin HS, and Mayer MM. Release of arachidonic acid and formation of oxygenated derivatives after complement attack on macrophages: role of channel formation. J Immunol 136: 4637-4643, 1986.
14. 2 synthesis. Eur J Pharmacol 107: 259-262, 1985.
15. Johnson A, Cooper JA, and Malik AB. Effect of complement activation with cobra venom factor on pulmonary vascular permeability (Abstract). J Appl Physiol 61: 2202, 1986.
16. Jorgensen KA, Kemp E, Barfort P, Starklint H, Larsen S, Petersen PH, and Knudsen JB. The survival of pig to rabbit renal xenografts during inhibition of thromboxane synthesis (Abstract). Thromb Res 32: 585, 1983.
17. Kambara K, Arakawa M, Segawa T, Ando F, Ohno M, and Kano A. Effects of acetylsalicylic acid on pulmonary vascular tone and permeability in blood-perfused dog lung. J Appl Physiol 75: 2561-2569, 1993.
18. 2 receptors on human endothelial cells. Circ Res 72: 958-965, 1993.
19. 2 mediates increased pulmonary microvascular permeability following limb ischemia. Circ Res 64: 1178-1189, 1989.
20. Kobayashi T, Taniguchi S, Neethling FA, Rose AG, Hancock WW, Ye Y, Niekrasz M, Kosanke S, Wright LJ, White DJG, and Cooper DKC. Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy. Transplantation 64: 1255-1261, 1997.
21. Kuhnle GE, Kuebler WM, Groh J, and Goetz AE. Effect of blood flow on the leukocyte-endothelium interaction in pulmonary microvessels (Abstract). Am J Respir Crit Care Med 152: 1221, 1995.
22. Laszlo F, Whittle BJ, and Moncada S. Interactions of constitutive nitric oxide with PAF and thromboxane on rat intestinal vascular integrity in acute endotoxaemia. Br J Pharmacol 113: 1131-1136, 1994.
23. Leeman M, Lejeune P, Hallemans R, Melot C, and Naeije R. Effects of increased pulmonary vascular tone on gas exchange in canine oleic acid pulmonary edema. J Appl Physiol 65: 662-668, 1988.
24. Lin SS and Platt JL. Immunologic barriers to xenotransplantation. J Heart Lung Transplant 15: 547-555, 1996.
25. McCurry KR, Kooymun DL, Alvarado CG, Cotterell AH, Martin MJ, Logan JS, and Platt JL. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nat Med 1: 423-428, 1995.
26. 2 during incompatible homologous and heterologous blood transfusion in sheep (Abstract). Anesthesiology 69: A122, 1988.
27. Needleman P and Johnson EM Jr. Vasodilators and the treatment of angina. In: Goodman and Gilman's The Pharmacologic Basis of Therapeutics (6th ed.). New York: Macmillan, 1980, p. 830.
28. Nowak J and FitzGerald GA. Redirection of prostaglandin endoperoxide metabolism at the platelet-vascular interface in man. J Clin Invest 83: 380-385, 1989.
29. Pascher A, Poehlein C, Storck M, Prestel R, Mueller-Hoecker J, White DJ, Abendroth D, and Hammer C. Immunopathological observations after xenogeneic liver perfusions using donor pigs transgenic for human decay-accelerating factor (Abstract). Transplantation 64: 384, 1997.
30. Pierson RN III, Kaspar-Konig W, Tew DN, Young VK, Dunning JJ, Hornsley J, Carey NRB, Wallwork J, and White DJG. Hyperacute lung rejection in a pig-to-human transplant model: the role of anti-pig antibody and complement. Transplantation 63: 594-603, 1997.
31. Pierson RN III, Pino-Chavez G, Young VK, Kaspar-Konig W, White DJG, and Wallwork J. Expression of human decay accelerating factor may protect pig lung from hyperacute rejection by human blood. J Heart Lung Transplant 16: 231-239, 1997.
32. Platt JL, Fischel RF, Matas AJ, Reif SA, Bolman RM, and Bach FH. Immunopathology of hyperacute xenograft rejection in a swine-to-primate model (Abstract). Transplantation 52: 214, 1991.
33. Pruitt SK, Kirk AD, Bollinger RR, Marsh HC Jr, Collins BH, Levin JL, Mault JR, Heinle JS, Ibrahim S, and Rudolph AR. The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation 57: 363-370, 1994.
34. 2. Am J Physiol Heart Circ Physiol 268: H1954-H1958, 1995.
35. Rowland M, Riegehnan S, Harris PA, and Sholkoff SD. Absorption kinetics of aspirin in man following oral administration of an aqueous solution (Abstract). J Pharm Sci 61: 379, 1972.
36. Saadi S and Platt JL. Transient perturbation of endothelial integrity induced by natural antibodies and complement. J Exp Med 181: 21-31, 1995.
37. Samuelsson B, Rydberg L, Breimer ME, Backer A, Gustavsson M, Holgersson J, Karlsson E, Uyterwaal AC, Cairns T, and Welsh K. Natural antibodies and human xenotransplantation. Immunol Rev 141: 151-168, 1994.
38. 2 analog on vascular resistance distribution and permeability in isolated blood-perfused dog lungs. Lung 173: 209-221, 1995.
39. Smith WJ, Murphy MP, Appleyard RF, Rizzo RJ, Aklog L, Laurence RG, and Cohn LH. Prevention of complement-induced pulmonary hypertension and improvement of right ventricular function by selective thromboxane receptor antagonism. J Thor Cardivasc Surg 107: 800-806, 1994.
40. Suckfull MM, Pieske O, Mudsam M, Babic R, and Hammer C. The contribution of endothelial cells to hyperacute rejection in xenogenic perfused working hearts, Transplantation 57: 262-267, 1994.
41. Van Rooijen N. The liposome-mediated macrophage "suicide" technique. J Immunol Methods 124: 1-6, 1989.
42. Welles SL, Shepro D, and Hechtman HB. Eicosanoid modulation of stress fibers in cultured bovine aortic endothelial cells. Inflammation 9: 439-450, 1985.
43. Yeatman M, Daggett CW, Parker W, Byrne GW, Logan JS, Platt JL, and Davis RD. Complement-mediated pulmonary xenograft injury. Transplantation 65: 1084-1093, 1998.
44. Zaidi A, Schmoeckel M, Bhatti F, Waterworth P, Tolan M, Cozzi E, Chavez G, Langford G, Thiru S, Wallwork J, White D, and Friend P. Life-supporting pig-to-primate renal xenotransplantation using genetically modified donors. Transplantation 65: 1584-1590, 1998.